The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder

Introduction Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on ca...

Full description

Bibliographic Details
Main Authors: A. Elias De Sousa, A.S. Machado, F. Andrade, M. Roque Gonçalves, M. Vieira-Coelho
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_article
_version_ 1797616901214437376
author A. Elias De Sousa
A.S. Machado
F. Andrade
M. Roque Gonçalves
M. Vieira-Coelho
author_facet A. Elias De Sousa
A.S. Machado
F. Andrade
M. Roque Gonçalves
M. Vieira-Coelho
author_sort A. Elias De Sousa
collection DOAJ
description Introduction Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on cannabis availability, as suggested by patients from our clinical practice, reporting a shortage of the substance. Objectives To compare sociodemographic, clinical characteristics and admission rates of inpatient treatment for cannabis-induced psychotic disorder in COVID-19 pandemic period and pre-pandemic period. Methods Retrospective observational study of inpatient admissions for CIPD in a psychiatry inpatient unit of a tertiary hospital. The statistical analysis was performed using SPSS software, version 27.0. Results Our sample included 120 inpatient admissions, corresponding to 80 patients. Compared to 2018 and 2019, in 2020 there was an overall reduction of 21.5% in inpatient admissions (n=618, 549 and 458, respectively). The number of admissions for CIPD in 2018, 2019, 2020 and 2021 up to september were, respectively, 29, 32, 10 and 31 (5.2%, 6.1%, 2.2% and 7.2% of respective annual admissions). We found no statistically significant differences regarding sociodemographic and clinical characteristics in patients admitted for CIPD during 2020. Conclusions These results suggest a disproportionate reduction of inpatient admissions due to CIPD in 2020, followed by an expressive increase in the number of admissions in 2021up to september. This might be related to cannabis availability returning to regular levels. However other factors must be considered, such as the delay of treatment due to reduced accessibility to health care. Disclosure No significant relationships.
first_indexed 2024-03-11T07:46:53Z
format Article
id doaj.art-092f20f190cf4718b4322fa015697c8e
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:46:53Z
publishDate 2022-06-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-092f20f190cf4718b4322fa015697c8e2023-11-17T05:07:19ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S793S79410.1192/j.eurpsy.2022.2051The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorderA. Elias De Sousa0A.S. Machado1F. Andrade2M. Roque Gonçalves3M. Vieira-Coelho4Centro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalFMUP, Departamento De Neurociências Clínicas E Saúde Mental, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, Portugal Introduction Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on cannabis availability, as suggested by patients from our clinical practice, reporting a shortage of the substance. Objectives To compare sociodemographic, clinical characteristics and admission rates of inpatient treatment for cannabis-induced psychotic disorder in COVID-19 pandemic period and pre-pandemic period. Methods Retrospective observational study of inpatient admissions for CIPD in a psychiatry inpatient unit of a tertiary hospital. The statistical analysis was performed using SPSS software, version 27.0. Results Our sample included 120 inpatient admissions, corresponding to 80 patients. Compared to 2018 and 2019, in 2020 there was an overall reduction of 21.5% in inpatient admissions (n=618, 549 and 458, respectively). The number of admissions for CIPD in 2018, 2019, 2020 and 2021 up to september were, respectively, 29, 32, 10 and 31 (5.2%, 6.1%, 2.2% and 7.2% of respective annual admissions). We found no statistically significant differences regarding sociodemographic and clinical characteristics in patients admitted for CIPD during 2020. Conclusions These results suggest a disproportionate reduction of inpatient admissions due to CIPD in 2020, followed by an expressive increase in the number of admissions in 2021up to september. This might be related to cannabis availability returning to regular levels. However other factors must be considered, such as the delay of treatment due to reduced accessibility to health care. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_articleCannabis-induced psychosisdrugsCannabispandemic
spellingShingle A. Elias De Sousa
A.S. Machado
F. Andrade
M. Roque Gonçalves
M. Vieira-Coelho
The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
European Psychiatry
Cannabis-induced psychosis
drugs
Cannabis
pandemic
title The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
title_full The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
title_fullStr The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
title_full_unstemmed The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
title_short The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
title_sort effect of covid 19 pandemic on admissions for cannabis induced psychotic disorder
topic Cannabis-induced psychosis
drugs
Cannabis
pandemic
url https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_article
work_keys_str_mv AT aeliasdesousa theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT asmachado theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT fandrade theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT mroquegoncalves theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT mvieiracoelho theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT aeliasdesousa effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT asmachado effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT fandrade effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT mroquegoncalves effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder
AT mvieiracoelho effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder